Olema Pharmaceuticals Cash Flow Statement (2020-2026) | OLMA

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-89.42M-42.72M-26.55M-36.40M-25.80M-26.57M-30.33M-51.62M-75.36M-27.13M-71.72M-67.53M-78.93M-33.78M-31.67M-45.75M-42.54M-46.38M-145.10M-131.35M
Share-based Compensation (Quarter)
4.16M15.77M4.96M4.73M4.28M0.11M4.63M4.17M0.09M16.93M0.20M5.72M0.05M-0.44M4.38M0.90M4.25M-12.42M10.15M12.90M
Cash from Operations (Quarter)
-12.10M-18.60M-17.90M-26.46M-17.99M-19.71M-20.39M-22.12M-22.74M-18.48M-23.50M-27.55M-27.02M-26.28M-43.98M-29.88M-34.53M-38.33M-45.99M-45.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.08M-0.06M-0.01M0.03M0.19M0.57M0.87M
Amortization of Deferred Charges (Quarter)
0.32M0.33M0.33M0.33M0.33M0.33M0.32M0.32M0.29M0.29M0.29M0.29M0.29M0.29M0.30M0.30M0.30M0.30M
Depreciation & Amortization (CF) (Quarter)
0.05M0.07M0.08M0.09M0.09M0.10M0.10M0.10M0.09M0.09M0.09M0.09M0.10M0.12M0.13M0.13M0.04M0.19M0.12M0.10M
Change in Working Capital
Change in Account Payables (Quarter)
-0.20M-0.16M0.24M-0.15M-0.11M0.36M0.31M0.94M0.58M0.49M4.96M-3.30M-1.67M2.52M-4.31M0.74M2.39M5.77M-5.68M-1.91M
Change in Accured Expenses (Quarter)
1.18M-0.50M-0.11M2.03M1.37M3.74M2.69M-5.38M0.47M5.17M-0.40M3.56M5.82M2.23M-11.25M12.70M5.90M3.63M1.30M8.03M
Other Working Capital Changes (Quarter)
-0.32M-0.32M-0.32M-0.32M-0.33M-0.33M-0.32M-0.26M-0.26M-0.29M-0.30M-0.30M-0.31M-0.31M-0.31M-0.31M-0.31M-0.31M
Investing Activities
Capital Expenditures (Quarter)
0.81M0.70M0.03M0.02M0.14M0.17M0.15M0.01M
Change in Acquisitions & Divestments (Quarter)
119.45M26.66M148.75M57.00M38.75M61.00M61.76M64.50M70.50M54.00M56.10M77.29M93.39M74.81M97.77M67.10M88.92M91.17M74.47M89.30M
Cash from Investing Activities (Quarter)
-12.78M6.00M25.57M29.41M20.16M16.34M37.39M14.11M-25.44M-30.91M-20.14M-4.88M45.92M-114.42M-45.08M34.23M17.27M-162.18M4.53M40.84M
Financing Activities
Other financing activities (Quarter)
0.06M0.48M0.03M0.01M0.11M0.22M1.33M0.87M127.31M0.92M0.07M0.09M242.42M0.24M0.23M0.04M7.88M8.43M-4.19M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
5.56M5.77M2.14M5.87M5.42M8.38M5.73M4.20M4.34M8.67M5.67M11.22M5.34M11.35M14.64M7.46M15.49M14.43M17.05M17.87M
Net Equity Issued and Repurchased (Quarter)
7.90M14.90M
Misc.
Cash from Financing Activities (Quarter)
0.06M0.82M0.03M0.06M0.11M0.27M0.22M2.04M130.63M0.52M8.82M15.61M0.09M244.30M0.22M-2.52M0.04M213.55M45.70M1.11M
Change in Cash (Quarter)
-24.82M-11.79M7.70M3.02M2.28M-3.10M17.22M-5.96M82.45M-48.87M-34.82M-16.83M19.00M103.59M-88.84M1.83M-17.21M13.04M4.25M-3.95M
Free Cash Flow (Quarter)
-12.91M-19.30M-17.93M-26.48M-18.13M-19.88M-20.39M-22.12M-22.74M-18.48M-23.65M-27.56M-27.02M-26.28M-43.98M-29.88M-34.53M-38.33M-45.99M-45.90M
Net Cash Flow (Quarter)
-24.82M-11.79M7.70M3.02M2.28M-3.10M17.22M-5.96M82.45M-48.87M-34.82M-16.83M19.00M103.59M-88.84M1.83M-17.21M13.04M4.25M-3.95M